Recombinant Rhesus monkey IFNB1 Protein, His-tagged
Cat.No. : | IFNB1-2206R |
Product Overview : | Recombinant Rhesus monkey IFNB1 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Rhesus monkey |
Tag : | His |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | IFNB1 interferon, beta 1, fibroblast [ Macaca mulatta (Rhesus monkey) ] |
Official Symbol : | IFNB1 |
Synonyms : | IFNB1; interferon beta; interferon beta 1; |
Gene ID : | 711414 |
mRNA Refseq : | NM_001135795 |
Protein Refseq : | NP_001129267 |
MIM : | |
UniProt ID : | B6CK14 |
Products Types
◆ Recombinant Protein | ||
Ifnb1-10566M | Recombinant Mouse Ifnb1 Protein, His (Fc)-Avi-tagged | +Inquiry |
IFNB1-2027R | Recombinant Rhesus Macaque IFNB1 Protein, His (Fc)-Avi-tagged | +Inquiry |
IFNB1-979P | Recombinant Pig IFNB1 Protein, His-tagged | +Inquiry |
IFNB1-2652R | Recombinant Rat IFNB1 Protein, His (Fc)-Avi-tagged | +Inquiry |
IFNB1-2724R | Recombinant Rhesus monkey IFNB1 Protein, His&GST-tagged | +Inquiry |
◆ Lysates | ||
IFNB1-001HCL | Recombinant Human IFNB1 cell lysate | +Inquiry |
IFNB1-2931HCL | Recombinant Human IFNB1 cell lysate | +Inquiry |
IFNB1-889CCL | Recombinant Cynomolgus IFNB1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionIFNB1 is generally not recommended for individuals with a history of hypersensitivity to interferons or other components of the drug. It should be used with caution in patients with certain pre-existing medical conditions.
IFNB1 is being investigated for its potential role in cancer treatment due to its immunomodulatory effects. Clinical trials are ongoing to evaluate its efficacy in various types of cancer.
Common side effects include flu-like symptoms, injection site reactions, and changes in blood cell counts. Serious side effects are rare but can include liver problems and allergic reactions.
IFNB1 is often administered through subcutaneous or intramuscular injections. The frequency and dosage depend on the specific condition being treated.
IFNB1 is also used in the treatment of certain viral infections, such as hepatitis B and C. It has antiviral properties that can inhibit viral replication.
Customer Reviews (3)
Write a reviewThe manufacturer not only ensures the provision of superior protein but also aids researchers with their solid technical support, offering the necessary resources to optimize experimental protocols.
the IFNB1 protein offers numerous advantages for researchers conducting trials due to its high quality and stability.
manufacturers or suppliers of proteins can play a crucial role in supporting researchers during trials.
Ask a Question for All IFNB1 Products
Required fields are marked with *
My Review for All IFNB1 Products
Required fields are marked with *
Inquiry Basket